AJR ARRS: Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katsumori, T.
Right arrow Articles by Tokuhiro, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katsumori, T.
Right arrow Articles by Tokuhiro, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2002; 178:135-139
© American Roentgen Ray Society


Uterine Artery Embolization Using Gelatin Sponge Particles Alone for Symptomatic Uterine Fibroids

Midterm Results

Tetsuya Katsumori1, Kazuhiro Nakajima, Tadashi Mihara and Mitsukuni Tokuhiro

1 All authors: Department of Radiology, Saiseikai Shiga Hospital, Ohashi 2-4-1, Ritto-cho, Kurita-gun, Shiga, 520-3046, Japan.

OBJECTIVE. The purpose of this study was to assess the safety and effectiveness of uterine artery embolization using gelatin sponge particles alone for women with symptomatic uterine fibroids.

SUBJECTS AND METHODS. During 38 months, 60 patients (age range, 32-52 years; mean age, 42.5 years) with symptomatic uterine fibroids underwent uterine artery embolization. Only gelatin sponge particles, approximately 500-1000 µm in diameter, were used in all patients. The improvement of clinical symptoms was assessed by questionnaire. Reduction of the largest tumor and uterine volume reductions were assessed using MR imaging. The follow-up period ranged from 1 to 38 months (mean, 10.6 months).

RESULTS. Menorrhagia improved markedly or moderately in 41 (98%) of 42 of patients 4 months after embolization and in 20 (100%) of 20 patients 1 year after embolization. Bulk-related symptoms improved markedly or moderately in 31 (97%) of 32 of patients 4 months after embolization and in 19 (100%) of 19 of patients 1 year after embolization. MR imaging revealed that the mean largest tumor volume reduction rates were 55% at 4 months and 70% at 1 year after embolization, and the mean uterine volume reduction rates were 40% at 4 months and 56% at 1 year after embolization. Follow-up MR imaging showed no new fibroids and no regrowth of existing fibroids. No major complications were observed in any women.

CONCLUSION. We suggest that uterine artery embolization with gelatin sponge particles alone is a safe and effective treatment for symptomatic fibroids. The outcomes bear comparison with those of uterine artery embolization using polyvinyl alcohol particles, which have been reported in the literature.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
G. Tropeano, S. Amoroso, and G. Scambia
Non-surgical management of uterine fibroids
Hum. Reprod. Update, May 1, 2008; 14(3): 259 - 274.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
J. B. Spies
Adding to our understanding of uterine fibroid embolization.
Am. J. Roentgenol., March 1, 2006; 186(3): 846 - 847.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. Katsumori, T. Kasahara, and K. Akazawa
Long-term outcomes of uterine artery embolization using gelatin sponge particles alone for symptomatic fibroids.
Am. J. Roentgenol., March 1, 2006; 186(3): 848 - 854.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. Katsumori, K. Akazawa, and T. Mihara
Uterine Artery Embolization for Pedunculated Subserosal Fibroids
Am. J. Roentgenol., February 1, 2005; 184(2): 399 - 402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Shimada, I. Ohashi, I. Kasahara, N. Miyasaka, and H. Shibuya
Triple-Phase Dynamic MRI of Intratumoral Vessel Density and Hyalinization Grade in Uterine Leiomyomas
Am. J. Roentgenol., April 1, 2004; 182(4): 1043 - 1050.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. Katsumori, K. Nakajima, and T. Mihara
Is a Large Fibroid a High-Risk Factor for Uterine Artery Embolization?
Am. J. Roentgenol., November 1, 2003; 181(5): 1309 - 1314.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
I. Imaoka, A. Wada, M. Matsuo, M. Yoshida, H. Kitagaki, and K. Sugimura
MR Imaging of Disorders Associated with Female Infertility: Use in Diagnosis, Treatment, and Management
RadioGraphics, November 1, 2003; 23(6): 1401 - 1421.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. J. Kroencke, A. Gauruder-Burmester, C. N.H. Enzweiler, M. Taupitz, and B. Hamm
Disintegration and stepwise expulsion of a large uterine leiomyoma with restoration of the uterine architecture after successful uterine fibroid embolization: Case report
Hum. Reprod., April 1, 2003; 18(4): 863 - 865.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Roentgen Ray Society.